190 related articles for article (PubMed ID: 4696355)
41. Hyperthermia associated with ophthalmic surgery.
Beasley H
Am J Ophthalmol; 1974 Jan; 77(1):76-9. PubMed ID: 4596135
[No Abstract] [Full Text] [Related]
42. Malignant hyperthermia.
Brown LL; Britt BA
South Med J; 1974 Jul; 67(7):799-804. PubMed ID: 4834737
[No Abstract] [Full Text] [Related]
43. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
[TBL] [Abstract][Full Text] [Related]
44. [Malignant hyperthermia. I. Observations in connection with its pathogenesis and course (author's transl)].
Plötz J; Braun J; Gericke B
Anaesthesist; 1980 Feb; 29(2):89-93. PubMed ID: 7377528
[TBL] [Abstract][Full Text] [Related]
45. Masseter contracture and tachycardia causing termination of anesthesia.
Burger BW; Malsch E; Mayer BW
Anesth Prog; 1984; 31(6):257-62. PubMed ID: 6597693
[TBL] [Abstract][Full Text] [Related]
46. Malignant hyperpyrexia.
Ellis FR
Anaesthesia; 1973 May; 28(3):245-52. PubMed ID: 4713948
[No Abstract] [Full Text] [Related]
47. Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice.
Kosko JR; Brandom BW; Chan KH
Int J Pediatr Otorhinolaryngol; 1992 Jan; 23(1):45-50. PubMed ID: 1592551
[TBL] [Abstract][Full Text] [Related]
48. Myoglobinuria after intermittent administration of succinylcholine during halothane anesthesia.
Airaksinen MM; Tammisto T
Clin Pharmacol Ther; 1966; 7(5):583-7. PubMed ID: 5957163
[No Abstract] [Full Text] [Related]
49. Prediction of malignant hyperthermia susceptibility by clinical signs.
Larach MG; Rosenberg H; Larach DR; Broennle AM
Anesthesiology; 1987 Apr; 66(4):547-50. PubMed ID: 3565822
[No Abstract] [Full Text] [Related]
50. [Cardiac dysrhythmias during halothane and enflurane anesthesia for dental procedures: a comparison].
Roelofse JA
S Afr Med J; 1983 Sep; 64(12):448-50. PubMed ID: 6623221
[TBL] [Abstract][Full Text] [Related]
51. Possible malignant hyperthermia in a 7-week-old infant.
Wilhoit RD; Brown RE; Bauman LA
Anesth Analg; 1989 May; 68(5):688-91. PubMed ID: 2634984
[No Abstract] [Full Text] [Related]
52. Rise in serum creatine phosphokinase associated with agents used in anaesthesia.
Takahashi T; Takasaki M; Namiki A; Dohi S
Br J Anaesth; 1973 Feb; 45(2):185-90. PubMed ID: 4704070
[No Abstract] [Full Text] [Related]
53. Malignant hyperpyrexia during general anesthesia. Successful management of a case.
Maisel RH; Sessions DG; Miller RN
Ann Otol Rhinol Laryngol; 1973; 82(5):729-33. PubMed ID: 4743403
[No Abstract] [Full Text] [Related]
54. Severe anaphylaxis to suxamethonium during oral surgery.
van der Westhuijzen A; Gomez CM; Towey RM
J Oral Maxillofac Surg; 1994 Nov; 52(11):1197-9. PubMed ID: 7965317
[No Abstract] [Full Text] [Related]
55. Malignant hyperthermia: screening of a family by serum-enzymes, electromyography and nerve-conduction.
Kratholm S; Nielsen E
Anaesth Resusc Intensive Ther; 1974; 2(4):359-63. PubMed ID: 4460754
[No Abstract] [Full Text] [Related]
56. Prevention of malignant hyperpyrexia.
Lancet; 1973 Jun; 1(7814):1225. PubMed ID: 4122568
[No Abstract] [Full Text] [Related]
57. Malignant hyperthermia.
Tsang HS; Schoenfeld FG
IMJ Ill Med J; 1976 May; 149(5):471-3. PubMed ID: 6381
[No Abstract] [Full Text] [Related]
58. [Malignant hyperthermia].
Hausmanowa-Petrusewicz I
Neurol Neurochir Pol; 1976; 10(5):609-11. PubMed ID: 980199
[No Abstract] [Full Text] [Related]
59. [A case of malignant hyperthermia occuring in a dental clinic].
Martel A; Spigelblatt L; Perreault L; Rosenfeld R
Can Anaesth Soc J; 1979 Jan; 26(1):55-7. PubMed ID: 761114
[TBL] [Abstract][Full Text] [Related]
60. Morbidity following dental extraction. A comparative survey of local analgesia and general anaesthesia.
Muir VM; Leonard M; Haddaway E
Anaesthesia; 1976 Mar; 31(2):171-80. PubMed ID: 937664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
